Patients in Kenya continue to pay higher prices for original or non-generic medicines years after patents expire, driven by entrenched prescribing habits, weak regulation, supply gaps, and market incentives that favour costlier products.
A spot check across Nairobi pharmacies shows significant price differences between branded and generic medicines.
